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Supplementary Material, Table 1 : Mass spectrometric parameters, precision and detection 
limits for analyses of phthalate metabolites.
Compound Mass Declustering Colission Precisiona Detectionb 
fragment potential (V) energy (V) (%) limit (ng/ml)
Monoethyl phthalate 193.1/77.2 -26 -28 11 1
Monobutyl phthalate 221.1/71.1 -26 -22 11 5
Monobenzyl phthalate 255.1/104.8 -26 -22 9 1
Monoethylhexyl phthalate 277.3/134.3 -26 -24 7 2
(MEHP)
5-hydroxy-MEHP 293.3/121.0 -16 -24 10 0.2
5-oxo-MEHP 291.3/77.0 -11 -40 34 0.6
2H4-Monoethyl phthalate 197.1/125.0 -26 -17 - -
2H4-Monobutyl phthalate 225.3/70.8 -26 -22 - -
13C4-Monobenzyl phthalate 259.0/107.0 -26 -18 - -
2H4-Monoethylhexyl 281.3/136.8 -26 -22 - -
phthalate (MEHP)
13C4-5-hydroxy-MEHP 297.3/123.8 -30 -25 - -
13C4-5-oxo-MEHP 295.3/124.0 -35 -26 - -
a Coefficient of variation of concentrations obtained in quality control samples analyzed in all
analysis series.
b Concentration corresponding to three times the standard deviation of the chemical blanks
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Supplementary Material, Table 2
Distribution of potential confounders according to exposure to MEHP in the cycle where women 
achieved a pregnancy (conception cycle). The group limits are based on tertiles of MEHP
exposure in samples from the conception cycle.
Potential confounders 1st group 2nd group 3rd group p-value a 
n=42 n=43 n=43
<LOD-9.9 ng/ml 9.9 – 22.0 ng/ml 22.0 -64.0 ng/ml
Age at enrollment in the 26.0 (21; 35) 25.1 (19; 32) 25.1 (20; 31) 0.44
study. Mean (min; max)
Alcohol (drinks/week). 4.8 (0; 39) 4.6 (0; 35) 4.9 (0; 15) 0.93
Mean (min; max)
Smoking (cigarettes/day) 1.4 (0; 20) 4.4 (0; 20) 1.5 (0; 17) 0.001
Mean (min; max) 
Caffeine intake (mg 273 (25; 973) 354 (0; 1017) 289 (6; 906) 0.21
caffeine/day). Mean
(min; max)
% with BMI <20.0 21.4 30.2 20.9 0.93
% with BMI 20.0-25.0 61.9 55.8 62.8
% with BMI >25.0 16.7 14.0 16.3
a ANOVA for continuous data and chi square test for categorical data.
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